Models adjust for physician medical specialty, sex and race/ethnicity of physician, years since residency graduation, relationship to social network member, medical practice size, employment type, proportion of uninsured patients in medical practice, full- vs part-time employment, and involvement in lawsuit for failure to diagnose cancer, with all covariates set at their means. Models used multiple imputation methods and chained equations to account for missing data.
aP < .001.
bP = .009.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Pollack CE, Radhakrishnan A, Parker AM, Chen X, Visvanathan K, Nowak SA. Association Between Physicians’ Experiences With Members of Their Social Network and Efforts to Reduce Breast Cancer Screening. JAMA Intern Med. 2018;178(1):148–151. doi:10.1001/jamainternmed.2017.6871
Physician recommendations strongly influence women’s decisions to receive breast cancer screening,1 but current evidence suggests physician adherence to evolving guidelines that recommend less screening is suboptimal.2,3 Clinical encounters and experiences with friends, colleagues, and family members who have been diagnosed with breast cancer may affect physician screening recommendations. These personal and professional experiences may provide physicians with anecdotal information about breast cancer screening fundamentally different from—and potentially at odds with—scientific evidence that relies on estimates of mortality reduction.4
With information from a national survey of gynecologists and primary care physicians, we investigated whether physician experiences with patients, friends, colleagues, and family members diagnosed with breast cancer were associated with their recommendations for breast cancer screening.
The Breast Cancer Social Networks study (CanSNET) is a national mailed survey fielded from May 2016 to September 2016 that included 2000 primary care physicians randomly selected from the American Medical Association Masterfile.3 Participants included gynecologists and internal medicine, family medicine, and general practice physicians who were surveyed about their breast cancer screening practices. Approval for this study was obtained from and signed patient consent was waived by the institutional review board at Johns Hopkins University School of Medicine.
Physicians reported up to 2 women members of their social network (1 patient and 1 friend or family member) who had been diagnosed with breast cancer and “whose cancer, broadly speaking, had the greatest impact” on them. Experiences of the individuals with breast cancer were categorized as follows: (1) diagnosed by screening, good prognosis; (2) not diagnosed by screening, good prognosis; (3) diagnosed by screening, poor prognosis; (4) not diagnosed by screening, poor prognosis; and (5) screening or prognosis unknown. Poor prognosis was defined as metastatic disease at diagnosis or dying of cancer. Physicians were asked whether they generally recommended routine screening mammograms to average-risk women (no family history or previous breast issues) in age groups for which existing guidelines are discordant (aged 40-44, 45-49, and ≥75 years). We used logistic regression models in SAS, version 9.4 (SAS Institute Inc), which adjusted for physician characteristics and used separate models for each age group, to test whether reporting at least 1 social network member in a diagnosis/prognosis category was associated with recommending routine breast cancer screening.
Of the 871 physicians who responded (adjusted response rate, 52.3%), 23 physicians did not report on any social network member, leaving a sample of 848 physicians. Of these, 461 (54.4%) were men, 379 (44.7%) were general practitioners or specialized in family medicine, 246 (29.0%) in internal medicine, and 223 (26.3%) in gynecology. These 848 physicians reported on 1631 social network members, including 771 patients, 381 family members, 474 other social network members, and 5 social network members with missing values for their position in the network (Table). Of the social network members, 305 of 1631 women (18.6%) had a poor prognosis, and more than half of these (163 women) were not diagnosed by breast cancer screening. There were 20 social network members with missing diagnosis or prognosis information.
Physicians who reported at least 1 social network member with a poor prognosis who was not diagnosed by screening were significantly more likely to recommend routine screening to women aged 40 to 44 years and those 75 years or older compared with physicians who did not report a social network member in this category (predicted probability for women aged 40-44 years: 92.7% vs 85.6%, P = .009; for women ≥75 years: 84.0% vs 68.3%, P < .001; Figure). The association between experiences and screening recommendations did not vary by the type of social network member (eg, patient, family member).
Physicians recounted detailed experiences of social network members, such as patients, friends, colleagues, and family members, who were diagnosed with breast cancer. Though the majority of physicians reported members who had good prognoses, a larger proportion of physicians recounted experiences with a poor prognosis than would be expected based on national averages (where 6% of women with breast cancer are diagnosed with distant disease).5 Disproportionate recall of these bad experiences is in line with the abundant behavioral literature that highlights how dreaded outcomes are more easily remembered, which can increase perceived risk.6 Describing a woman whose breast cancer was not diagnosed by screening mammogram and who had a poor prognosis was associated with increased odds of recommending routine screening to patients within the designated younger and older age groups for which guidelines no longer support routine, universal screening. Our results suggest that helping clinicians reflect on how their experiences influence their current screening patterns may be an important approach to improve adherence to revised breast cancer screening guidelines.
Corresponding Author: Craig Evan Pollack, MD, MHS, Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, 2024 E Monument St, Ste 2-615, Baltimore, MD 21287 (email@example.com).
Accepted for Publication: October 4, 2017.
Published Online: December 4, 2017. doi:10.1001/jamainternmed.2017.6871
Author Contributions: Dr Pollack had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Pollack, Parker, Nowak.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Pollack, Nowak.
Critical revision of the manuscript for important intellectual content: Radhakrishnan, Parker, Chen, Visvanathan, Nowak.
Statistical analysis: Radhakrishnan, Chen, Nowak.
Obtained funding: Pollack, Nowak.
Administrative, technical, or material support: Pollack.
Study supervision: Pollack.
Conflict of Interest Disclosures: At the time of the study, Dr Pollack’s salary was supported by a grant from the National Cancer Institute and Dr Radhakrishnan’s salary was supported by a grant from the National Heart, Lung, and Blood Institute.
Funding/Support: This study was supported by grant R21CA194194-02 from the National Cancer Institute (Drs Pollack and Nowak).
Role of the Funder/Sponsor: The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Meeting Presentation: This work was presented at the annual meeting of the American Society of Clinical Oncology; June 5, 2017; Chicago, Illinois.
Additional Contributions: Joseph Huntley, BS, provided assistance with manuscript preparation. Anwar Battle and Paul Sharrett assisted with survey administration. All individuals are affiliated with Johns Hopkins University, and all individuals were financially compensated for their time.